Comprehensive Metabolomics in Mouse Mast Cell Model of Allergic Rhinitis for Profiling, Modulation, Semiquantitative Analysis, and Pathway Analysis

Allergic rhinitis affects millions globally, causing significant discomfort and reducing the quality of life. This study investigates the metabolic alterations in murine mast cells (MC/9) under allergic rhinitis conditions induced by lipopolysaccharide (LPS) stimulation, employing UHPLC-QTOF-MS-base...

Full description

Saved in:
Bibliographic Details
Main Authors: Akshay Suresh Patil, Yan Xu
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/15/1/109
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588888629051392
author Akshay Suresh Patil
Yan Xu
author_facet Akshay Suresh Patil
Yan Xu
author_sort Akshay Suresh Patil
collection DOAJ
description Allergic rhinitis affects millions globally, causing significant discomfort and reducing the quality of life. This study investigates the metabolic alterations in murine mast cells (MC/9) under allergic rhinitis conditions induced by lipopolysaccharide (LPS) stimulation, employing UHPLC-QTOF-MS-based untargeted and targeted metabolomics. The analysis identified 44 significantly regulated metabolites, including histamine, leukotrienes, prostaglandins, thromboxanes, and ceramides. Key metabolic pathways such as arachidonic acid, histidine, and sphingolipid metabolisms were notably modulated. The study further examined the therapeutic effects of triprolidine and zileuton, demonstrating their capacity to reverse LPS-induced metabolic shifts. Triprolidine primarily modulated histidine and sphingolipid metabolism, while zileuton targeted arachidonic acid and sphingolipid metabolism. These findings underscore the utility of metabolomics analysis in elucidating the complex biochemical pathways involved in allergic rhinitis and highlight the potential of metabolomics for evaluating therapeutic interventions. This study enhances our understanding of mast cell metabolism in allergic responses and provides a robust model for assessing the efficacy of anti-allergic agents, paving the way for more effective treatments.
format Article
id doaj-art-1edc17dd3f7343d7a2190ddde78afeff
institution Kabale University
issn 2218-273X
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj-art-1edc17dd3f7343d7a2190ddde78afeff2025-01-24T13:25:13ZengMDPI AGBiomolecules2218-273X2025-01-0115110910.3390/biom15010109Comprehensive Metabolomics in Mouse Mast Cell Model of Allergic Rhinitis for Profiling, Modulation, Semiquantitative Analysis, and Pathway AnalysisAkshay Suresh Patil0Yan Xu1Department of Chemistry, Cleveland State University, Cleveland, OH 44115, USADepartment of Chemistry, Cleveland State University, Cleveland, OH 44115, USAAllergic rhinitis affects millions globally, causing significant discomfort and reducing the quality of life. This study investigates the metabolic alterations in murine mast cells (MC/9) under allergic rhinitis conditions induced by lipopolysaccharide (LPS) stimulation, employing UHPLC-QTOF-MS-based untargeted and targeted metabolomics. The analysis identified 44 significantly regulated metabolites, including histamine, leukotrienes, prostaglandins, thromboxanes, and ceramides. Key metabolic pathways such as arachidonic acid, histidine, and sphingolipid metabolisms were notably modulated. The study further examined the therapeutic effects of triprolidine and zileuton, demonstrating their capacity to reverse LPS-induced metabolic shifts. Triprolidine primarily modulated histidine and sphingolipid metabolism, while zileuton targeted arachidonic acid and sphingolipid metabolism. These findings underscore the utility of metabolomics analysis in elucidating the complex biochemical pathways involved in allergic rhinitis and highlight the potential of metabolomics for evaluating therapeutic interventions. This study enhances our understanding of mast cell metabolism in allergic responses and provides a robust model for assessing the efficacy of anti-allergic agents, paving the way for more effective treatments.https://www.mdpi.com/2218-273X/15/1/109UHPLC-QTOF-MS-based untargeted and targeted metabolomicssemiquantitative analysismast cell modulationpathway analysistherapeutic agent testing
spellingShingle Akshay Suresh Patil
Yan Xu
Comprehensive Metabolomics in Mouse Mast Cell Model of Allergic Rhinitis for Profiling, Modulation, Semiquantitative Analysis, and Pathway Analysis
Biomolecules
UHPLC-QTOF-MS-based untargeted and targeted metabolomics
semiquantitative analysis
mast cell modulation
pathway analysis
therapeutic agent testing
title Comprehensive Metabolomics in Mouse Mast Cell Model of Allergic Rhinitis for Profiling, Modulation, Semiquantitative Analysis, and Pathway Analysis
title_full Comprehensive Metabolomics in Mouse Mast Cell Model of Allergic Rhinitis for Profiling, Modulation, Semiquantitative Analysis, and Pathway Analysis
title_fullStr Comprehensive Metabolomics in Mouse Mast Cell Model of Allergic Rhinitis for Profiling, Modulation, Semiquantitative Analysis, and Pathway Analysis
title_full_unstemmed Comprehensive Metabolomics in Mouse Mast Cell Model of Allergic Rhinitis for Profiling, Modulation, Semiquantitative Analysis, and Pathway Analysis
title_short Comprehensive Metabolomics in Mouse Mast Cell Model of Allergic Rhinitis for Profiling, Modulation, Semiquantitative Analysis, and Pathway Analysis
title_sort comprehensive metabolomics in mouse mast cell model of allergic rhinitis for profiling modulation semiquantitative analysis and pathway analysis
topic UHPLC-QTOF-MS-based untargeted and targeted metabolomics
semiquantitative analysis
mast cell modulation
pathway analysis
therapeutic agent testing
url https://www.mdpi.com/2218-273X/15/1/109
work_keys_str_mv AT akshaysureshpatil comprehensivemetabolomicsinmousemastcellmodelofallergicrhinitisforprofilingmodulationsemiquantitativeanalysisandpathwayanalysis
AT yanxu comprehensivemetabolomicsinmousemastcellmodelofallergicrhinitisforprofilingmodulationsemiquantitativeanalysisandpathwayanalysis